Literature DB >> 29120838

Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in Yap, Federated States of Micronesia.

Angela U Sy1, Brenda Y Hernandez2, Aileen Tareg3, Martina Reichhardt3, Lee Buenconsejo-Lum4.   

Abstract

Non-invasive, self-collected sampling methods for HPV DNA detection in women, which are reliable, efficient, and acceptable have the potential to address barriers to cervical cancer screening in underserved communities, including low-middle income countries (LMIC) such as the island nation of the Federated States of Micronesia (FSM). Urine-based HPV testing has not been rigorously evaluated in clinical trials. A pilot community-based participatory randomized control research project evaluated use of urine HPV testing as a more culturally- and human resource appropriate method of cervical cancer screening in Yap State, FSM. Women participated in a cervical screening intervention using pap vs. urine test (N=217). This manuscript described attitudes about screening feasibility and preferences. Stakeholders and women participants were interviewed (N=23), and a survey also evaluated women's screening preferences (N=217). Qualitative content thematic analysis with multiple coders identified themes from interviews on acceptability and feasibility of screening tests. Women research participants were comfortable with the urine test (95%), despite limitations in some to provide samples. While 82.0% indicated that they felt comfortable with Pap smear, they also preferred a clinician (42%) to do the Pap smear, explaining that they preferred having a trained worker instead of themselves to do tests. Women want to be screened but accessibility remains a challenge. Education and training of professionals and community members alike will improve clinical skills, research capacity, knowledge of screening tests and behaviors including prioritizing HPV screening and testing.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer screening; Community based participatory research; Early detection of cancer; Female; Human papillomavirus; Pacific Islands; Papillomavirus infections; Prevention and control; Translational research

Mesh:

Substances:

Year:  2017        PMID: 29120838      PMCID: PMC5739880          DOI: 10.1016/j.canep.2017.07.008

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  10 in total

1.  International Participatory Research Framework: triangulating procedures to build health research capacity in Brazil.

Authors:  Rogério M Pinto; Sueli Bulhões da Silva; Cláudia Penido; Anya Y Spector
Journal:  Health Promot Int       Date:  2011-12-05       Impact factor: 2.483

2.  The path to eliminate cervical cancer in the world and the challenges of professional education.

Authors:  F Xavier Bosch
Journal:  Vaccine       Date:  2013-12-29       Impact factor: 3.641

3.  Evaluation of genital self-sampling methods for HPV detection in males.

Authors:  Brenda Y Hernandez; Lynne R Wilkens; Elizabeth R Unger; Martin Steinau; Lauri Markowitz; Keiko Garvin; Pamela J Thompson; Yurii B Shvetsov; Kristen O'Dillon; Eileen F Dunne
Journal:  J Clin Virol       Date:  2013-07-20       Impact factor: 3.168

4.  Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials.

Authors:  Claudia Pileggi; Domenico Flotta; Aida Bianco; Carmelo G A Nobile; Maria Pavia
Journal:  Int J Cancer       Date:  2014-01-24       Impact factor: 7.396

5.  Community-based participatory research contributions to intervention research: the intersection of science and practice to improve health equity.

Authors:  Nina Wallerstein; Bonnie Duran
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

6.  Committee Opinion No. 624: Cervical cancer screening in low-resource settings.

Authors: 
Journal:  Obstet Gynecol       Date:  2015-02       Impact factor: 7.661

7.  Operationalization of community-based participatory research principles: assessment of the national cancer institute's community network programs.

Authors:  Kathryn L Braun; Tung T Nguyen; Sora Park Tanjasiri; Janis Campbell; Sue P Heiney; Heather M Brandt; Selina A Smith; Daniel S Blumenthal; Margaret Hargreaves; Kathryn Coe; Grace X Ma; Donna Kenerson; Kushal Patel; JoAnn Tsark; James R Hébert
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

Review 8.  Human papillomavirus and cervical cancer.

Authors:  Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana C Rodriguez; Sholom Wacholder
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

Review 9.  Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

Authors:  Marc Arbyn; Guglielmo Ronco; Ahti Anttila; Chris J L M Meijer; Mario Poljak; Gina Ogilvie; George Koliopoulos; Pontus Naucler; Rengaswamy Sankaranarayanan; Julian Peto
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

10.  Transmission of human papillomavirus in heterosexual couples.

Authors:  Brenda Y Hernandez; Lynne R Wilkens; Xuemei Zhu; Pamela Thompson; Katharine McDuffie; Yurii B Shvetsov; Lori E Kamemoto; Jeffrey Killeen; Lily Ning; Marc T Goodman
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

  10 in total
  8 in total

1.  Public Engagement with Biotechnology Inside and Outside the Classroom: Community-Focused Approaches.

Authors:  Jorge Jimenez; Joyonna Gamble-George; Giovanna Danies; Ronda L Hamm; Ana Maria Porras
Journal:  GEN Biotechnol       Date:  2022-08-18

Review 2.  Best Practices for Community-Engaged Research with Pacific Islander Communities in the US and USAPI: A Scoping Review.

Authors:  Pearl A McElfish; Karen Yeary; Imi A Sinclair; Susan Steelman; Monica K Esquivel; Nia Aitaoto; Keawe'aimoku Kaholokula; Rachel S Purvis; Britni L Ayers
Journal:  J Health Care Poor Underserved       Date:  2019

3.  Randomized controlled trial evaluating the utility of urine HPV DNA for cervical cancer screening in a Pacific Island population.

Authors:  Brenda Y Hernandez; Aileen C Tareg; Martina Reichhardt; Angelica Agapito; Xuemei Zhu; Angela Sy; Arnice Yuji; Jeffrey Killeen; Owen Chan; Lee E Buenconsejo-Lum
Journal:  J Glob Health Rep       Date:  2018-07-06

4.  Difficulties in Accessing Cancer Care in a Small Island State: A Community-Based Pilot Study of Cancer Survivors in Saint Lucia.

Authors:  Aviane Auguste; Glenn Jones; Dorothy Phillip; James St Catherine; Elizabeth Dos Santos; Owen Gabriel; Carlene Radix
Journal:  Int J Environ Res Public Health       Date:  2021-04-29       Impact factor: 3.390

5.  HPV self-sampling for cervical cancer screening: a systematic review of values and preferences.

Authors:  Holly Nishimura; Ping Teresa Yeh; Habibat Oguntade; Caitlin E Kennedy; Manjulaa Narasimhan
Journal:  BMJ Glob Health       Date:  2021-05

6.  A biomarker feasibility study in the South East Asia Community Observatory health and demographic surveillance system.

Authors:  U Partap; E H Young; P Allotey; M S Sandhu; D D Reidpath
Journal:  Glob Health Epidemiol Genom       Date:  2018-08-22

7.  Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening.

Authors:  Caroline Lefeuvre; Hélène De Pauw; Anne-Sophie Le Duc Banaszuk; Adeline Pivert; Alexandra Ducancelle; Franck Rexand-Galais; Marc Arbyn
Journal:  Int J Public Health       Date:  2022-02-24       Impact factor: 3.380

8.  Performance of an affordable urine self-sampling method for human papillomavirus detection in Mexican women.

Authors:  Rubí Hernández-López; Luis Hermosillo; Leith León-Maldonado; Rafael Velázquez-Cruz; Leticia Torres-Ibarra; Eduardo Lazcano-Ponce; Attila Lörincz; Cosette M Wheeler; F Xavier Bosch; Jack Cuzick; Berenice Rivera-Paredez; Belinda Nedjai; Jorge Salmerón
Journal:  PLoS One       Date:  2021-07-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.